
WuXi Biologics
WuXi Biologics - Discovery, Development, Manufacturing - CDMO - CMO. Spun out of WuXi AppTec.
HQ location
Xuancheng, China
Website
Launch date
Employees
Market cap
$12.6b
Enterprise value
$11.9b
Share price
HKD25.65 2269.HK
Recent deals
loading funding rounds…

Sequoia(exited)

Ally Bridge Group(exited)

Temasek(exited)

WuXi AppTec(exited)

General Atlantic(exited)

HongShan(exited)

Dinghang Capital(exited)
CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 83 % | 48 % | 12 % | 10 % | 14 % | 15 % | 15 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 42 % | 46 % | 33 % | 43 % | 34 % | 35 % | 35 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 33 % | 29 % | 20 % | 18 % | 19 % | 19 % | 20 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 5 % | 4 % | 5 % | 4 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by WuXi Biologics
Edit
exited

ACQUISITION by Dechra Pharmaceuticals Jul 2024

exited